Other conferences by IBC »
You are here: Home
Asia’s No 1 Generics Drug Event

Featuring NEW speaker:
Billy Urudra,
Chief Commercial Officer, CCM Pharmaceuticals Division, Malaysia
Sandeep Rathod, AVP-IP, Mylan Laboratories¸ India
Vijay Karwal, Managing Director, Head of Industrials, Consumer & Healthcare Investment Banking, CIMB, Hong Kong

Event Overview

2013 is proving to be an exceptionally exciting year for the generics industry. Amidst the rise of Asia’s wealth, competition to grow the market within greater government presence and complex cultures have posed problems for MNCs. Meanwhile, local generic players with homeground advantages, fight to protect quality standards while searching for ways to diversify their own product portfolio.

IBC’s 8th annual Generics Asia 2013 will continue to provide an open platform, bringing together innovators, generic companies, investors and end-payers in a 4 day gathering of dialogue and exchanging of ideas.

Rave Reviews from 2012 Attendees

Event was very informative and I got connected with many new people – Mahmood, Getz Pharma

Very informative, well organized and enlightening – Krystal, Eisai Malaysia

Interesting topics and speaker line up. – Deepak, Dr Reddy’s

Very interactive sessions and informative. Beneficial to have ideas to explore possibilities – Shariza, CCM Pharmaceuticals

Topical Issues to be Addressed This Year include
  • MNCs are having to relook at their evergreening strategies as traditional pay-for-delays and patent extension are under greater scrutiny by governments
  • With governments pushing for greater patient access, the pharma industry is facing big price cuts affecting profitability.
  • In self-paying Asia, gaining insights into the end buyer’s needs and wants would affect how the pharma position/brand/market themselves
  • Over the past few years, the market was flooded with news of M&As and collaborations, however, the results are now bearing fruit. Is there a future in MNC and local partnerships?
  • Facing the dilemma of which market to enter
  • Product portfolio expansion – inhouse or through purchasing? Biosimilars or supergenerics?
  • How can other players such as CMOs, CROs, drug delivery companies all contribute to growing the supergenerics portfolio?


2013 Speaker Panel Includes:

Shanti Shamdasani
Regional Director Government Affairs – ASEAN
Johnson & Johnson
Jingyi Yu
Manager, Generics & Biosimilar Business, Strategy & Business Development
Jose Ochave
Senior Vice President, Business Development
Debbie Pangan
Corporate Affairs Director
The Generics Pharmacy

See Full Speaker Line Up, click here »

Pre-Conference Workshop A: Tuesday, 11 November 2013
Go-to-Market Innovation: Increasing Awareness, Access & Margins

To View Workshop details, click here »

Choose Your Language

 Register Now
Register Online
+65 6508 2401
+65 6508 2407
Customer Services

Download Prospectus

 Quick Links

 Connect Now
Add to Calendar
Add to Favourites
Register for E-update

Produced By Luncheon Sponsor    

Media Partners